What does CUSIP 76135L309 represent in this 13F holders report?

CUSIP 76135L309 is the security identifier for REVB - REVELATION BIOSCIENCES INC - COM NEW used to aggregate holder disclosures.

How many institutions held REVB - REVELATION BIOSCIENCES INC - COM NEW in Q2 2023?

8 institutional investors reported REVB - REVELATION BIOSCIENCES INC - COM NEW for Q2 2023. Use the holders table for investor-level position and value details.

REVELATION BIOSCIENCES INC - COM NEW (REVB)

CUSIP: 76135L309

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / COM NEW
Total 13F shares: 805,063
Share change: -943
Total reported value: $758,688
Price per share: $0.94
Number of holders: 8
Value change: -$142,359
Number of buys: 6
Number of sells: 5

Quarterly Holders Quick Answers

What is CUSIP 76135L309?
CUSIP 76135L309 identifies REVB - REVELATION BIOSCIENCES INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 76135L309:

Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023

Institutional Holders of REVELATION BIOSCIENCES INC - COM NEW (REVB) as of Q2 2023

As of 30 Jun 2023, REVELATION BIOSCIENCES INC - COM NEW (REVB) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 805,063 shares. The largest 8 holders included SABBY MANAGEMENT, LLC, Walleye Capital LLC, Virtu Financial LLC, AXA S.A., HRT FINANCIAL LP, Tower Research Capital LLC (TRC), MORGAN STANLEY, and WELLS FARGO & COMPANY/MN. This page lists 8 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.